151
Views
105
CrossRef citations to date
0
Altmetric
Research Article

Emerging molecular mechanisms of brain tumour oedema

Pages 101-108 | Published online: 06 Jul 2009

  • Thapar K, Rutka JT, Laws ER Jr. Brain edema, increased intracranial pressure, vascular effects, and other epiphenomena of human brain tumors. In: Kaye AH, Laws ER, editors. Brain tumors: an encyclopedic approach. Edinburgh: Churchill Livingstone, 1995:163-89.
  • Klatzo I. Neuropathological aspects of brain oedema. J Neuropathol Exp Neurol 1967;26:1-14.
  • Fishman RA. Brain edema. N Engl J Med 1975;293:706-11.
  • Ehrlich P. Das sauerstoff-bedurnfniss des oraganismus. Eine farbenanalytische Studie. Berlin: Hirschwold, 1885.
  • Reese TS, Karnovsky MJ. Fine structure localization of a blood brain barrier to exogenous peroxidase. J Cell Biol 1967;34:207-17.
  • Sage MR, Wilson AJ, Scroop R. Contrast media and the brain. The basis of CT and MR imaging enhancement. Neuroim Clin N Am 1998;8:695-707.
  • Rubin LL, Staddon JM. The cell biology of the blood-brain barrier. Ann Rev Neurosci 1999;22:11-28.
  • Bar-Sella P, Front D, Hardoff R, Peyser E, Borovich B, Nir I. Ultrastructural basis for different pertechnetate uptake patterns by various human brain tumors. J Neurol Neurosurg Psychiatry 1979;42:924-30.
  • Hayashi Y, Nomura M, Yamagishi S-I, Harada S-I, Yamashida J, Yamamoto H. Induction of various blood-brain barrier properties in non-neural endothelial cells by close apposition to co-cultured astrocytes. Glia 19997;19:13-26.
  • Janzer RC, Raff MC. Astrocytes induce blood-brain barrier properties in endothelial cells. Nature 1987;325:253-7.
  • Underwood JL, Murphy CG, Chen J, et al. Glucocorticoids regulate transendothelial fluid flow resistance and formation of intercellular junctions. Am J Physiol 1999;277:C330-42.
  • Groothuis DR, Vriesendorp FJ, Kupfer B, et al. Quantitative measurements of capillary transport in human brain tumors by computed tomography. Ann Neurol 1991;30:581-8.
  • Seitz RJ, Wechsler W. Immunohistochemical demonstration of serum proteins in human cerebral gliomas. Acta Neuropathol (Berl) 1987;73:145-52.
  • Machein RM, Kullmer J, Fibich BL, Plate KH, Warnke PC. Vascular endothelial growth factor expression, vascular volume and capillary permeability in human brain tumors. Neurosurgery 1999;44:732-41.
  • Bates, DO, Lodwick D, Williams B. Vascular endothelial growth factor and microvascular permeability. Microcirculation 1999;6:83-96.
  • Connolly DT. Vascular permeability factor: a unique regulator of blood vessel function. J Cell Biochem 1991;47:219-33.
  • Stevenson BR, Siciliano JD, Mooseker MS, Goodenough DA. Identification of ZO-1: a high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia. J Cell Biol 1986;103:755-66.
  • Gumbiner B, Lowenkopf T, Apatira D. Identification of a 160-kDa polypeptide that binds to the tight junction protein ZO-1. Proc Nat Acad Sci USA 1991;88:3460-4.
  • Haskins J, Gu L, Wittchen ES, Hibbard J, Stevenson BR. ZO-3, a novel member of the MAGUK protein family found at the tight junction, interacts with ZO-1 and occludin. J Cell Biol 1998;141:199-208.
  • Furuse M, Hirase T, Itoh M, et al. Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol 1993;123:1777-88.
  • Tsukita S, Furuse M. Occludin and claudins in tight-junction strands: leading or supporting players? Trends Cell Biol 1999;9:268-74.
  • Hirase T, Staddon JM, Saitou M, et al. Occludin as a possible determinant of tight junction permeability in endothelial cells. J Cell Sci 1997;110:1603-13.
  • Morita K, Sasaki H, Furuse M, Tsukita S. Endothelial claudin: claudin 5/TMVCF constitutes tight junction strands in endothelial cells. J Cell Biol 1999;147:185-94.
  • Watson PM, Anderson JM, Vanitallie CM, Doctrow SR. The tight-junction-specific protein ZO-1 is a component of the human and rat blood-brain barriers. Neurosci Lett 1991;129:6-10.
  • Fanning AS, Jameson BJ, Jesaitis LA, Anderson JM. The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton. J Biol Chem 1998;273:29745-53.
  • Itoh M, Furuse M, Morita K, Saitou M, Tsukita S. Direct binding of the three tight junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins. J Cell Biol 1999;147:1351-63.
  • Grieg NH. Brain tumors and the blood-brain barrier. In: Neuwelt EA, editor. Implications of the blood-brain barrier and its manipulation. New York: Plenum Press, 1989:77-106.
  • Shibata T. Ultrastructure of capillary walls in human brain tumors. Acta Neuropathol (Berl) 1989;78:561-71.
  • Nir I, Levanon D, Iosilevsky G. Permeability of blood vessels in experimental gliomas: Uptake of [sup 99m]Tc-glucoheptonate and alteration in blood-brain barrier as determined by cytochemistry and electron microscopy. Neurosurgery 1989;25:523-32.
  • Long D. Capillary ultrastructure in human metastatic brain tumors. J Neurosurg 1979;51:409-19.
  • Stewart P, Hayakawa K, Farrell CL, Del Maestro RF. Quantitative study of microvessel ultrastructure in human peritumoral brain tissue: evidence for a blood-brain barrier defect. J Neurosurg 1987;67:697-705.
  • Wan H, Winton HL, Soeller G, et al. Der p 1 facilitates transepithelial allergen delivery by disruption of tight junctions. J Clin Invest 1999;104:123-33.
  • Leroy A, Lauwaet T, De Bruyne G, Corelissen M, Mareel M. Entamoeba histolytica disturbs the tight junction complex in human enteric T84 cell layers. FASEB J 2000;14:1139-46.
  • Brown H, Hien TT, Day N, et al. Evidence of blood-brain barrier dysfunction in human cerebral malaria. Neuropathol Appl Neurobiol 1999;25:331-40.
  • Antcliff RJ, Marshall J. The pathogenesis of edema in diabetic maculopathy. Semin Ophthalmol 1999;14:223-32.
  • Papadopoulos MC, Saadoun S, Woodrow CJ, et al. Loss of occludin expression: possible cause of brain tumour oedema. Soc Br Neurol Surg Meeting, Glasgow, Scotland, 2000 (Abstr.).
  • Papadopoulos MC, Saadoun S, Davies DC, Bell BA. New molecular models of brain tumour oedema. 7th Br Neurosurg Res Group Meeting, Newcastle, UK 2000 (Abstr.).
  • Liebner S, Fischmann A, Rascher G, Duffner F, Grote EH, Kalbacher H, Wolburg H. Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme. Acta Neuropathol (Berl) 2000;100:323-31.
  • Sawada T, Kato Y, Kobayashi M, Takekekawa Y. Immunohistochemical study of tight junction-related protein in neovasculature in astrocytic tumor. Brain Tumor Path 2000;17:1-6.
  • Staddon J, Ratcliffe M, Morgan L, Hirase T, Smales C, Rubin L. Protein phosphorylation and the regulation of cell-cell junctions in brain endothelial cells. Heart Vessels 1997;12:106-9.
  • Antonetti DA, Barber AJ, Hollinger LA, Wolpert EB, Gardner TW. Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1. J Biol Chem 1999;274:23463-7.
  • Risau W, Esser S, Engelhardt B. Differentiation of blood-brain barrier endothelial cells. Pathol Biol 1998;46:171-5.
  • Plate KH, Breier G, Weich HA, Mennel HD, Rissau W. Vascular endothelial growth factor and glioma angiogenesis, coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. Int J Cancer 1994;59:520-9.
  • Valter MM, Hugel A, Huang HJ, et al. Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Fit-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis. Cancer Res 1999;59:5608-14.
  • Nag S, Takahashi JT, Kilty DW. Role of vascular endothelial growth factor in blood-brain barrier breakdown and angiogenesis in brain trauma. J Neuropathol Exp Neurol 1997;56:912-21.
  • Papavassiliou E, Gogate N, Proescholdt M, et al. Vascular endothelial growth factor (vascular permeability factor) expression in injured rat brain. J Neurosci Res 1997;49:451-60.
  • Giaccia AJ. Hypoxic stress proteins: survival of the fittest. Semin Radiat Oncol 1996;6:46-58.
  • Shibata T, Giaccia AJ, Brown JM. Development of a hypoxia-responsive vector for tumor-specific gene therapy. Gene Ther 2000;7:493-8.
  • Plate KH, Warnke PC. Vascular endothelial growth factor. J Neurooncol 1997;35:365-72.
  • Reulen H-J, Huber P, Ito U, Groger U. Peritumoral brain oedema. Adv Neurol 1990;52:307-15.
  • Nielsen S, Nagelhus EA, Amiry-Moghaddam M, Bourque C, Agre P, Ottersen OP. Specialized membrane domains for water transport in glial cells: high resolution immunogold cytochemistry of aquaporin-4 in the rat brain. J Neurosci 1997;17:171-80.
  • Vizuete ML, Venero JL, Vargas C, et al. Differential upregulation of aquaporin-4 mRNA expression in reactive astrocytes after brain injury: potential role in brain oedema. Neurobiol Dis 1999;6:245-58.
  • Vajda Z, Promeneur D, Doczi T, et al. Increased aquaporin-4 immunoreactivity in rat brain in response to systemic hyponatremia. Biochem Biophys Res Commun 2000;13:495-503.
  • Manley GT, Folkesson HG, Ma T, Verkman AS. Altered cerebral water balance after water intoxication in aquaporin-4 knockout mice. 11th International Symposium on Brain Oedema, 0-18, 1999 (Abstr.).
  • Manley GT, Fujimura M, Ma T, et al. Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat Med 2000;6:159-63.
  • Muresan Z, Paul DL, Goodenough DA. Occludin 1B, a variant of the tight junction protein occludin. Mol Biol Cell 2000;11:627-34.
  • Martin-Padura I, Lostaglio S, Schneemann M, P et al. Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J Cell Biol 1998;142:117-27.
  • Furuse M, Fujita K, Hiiragi T, Fujimoto K, Tsukita, Sh. Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol 1998;141:1539-50.
  • Morita K, Furuse M, Fujimoto K, Tsukita, S. Claudin multigene family encoding four-transmembrane domain protein components at tight junction strands. J Cell Biol 1999;96:511-16.
  • Morita K, Sasaki H, Fujimoto K, Furuse M, Tsukita S. Claudin-11/OSP-based tight junctions of myelin sheaths in brain and Sertoli cells in testis. J Cell Biol 1999;145:579-88.
  • Citi S, Sabanay H, Jakes R, Geiger B, Kendrick-Jones J. Cingulin, a new peripheral component of tight junctions. Nature 1988;333:272-6.
  • Keon BH, Schafer S, Kuhn C, Grund C, Franke WW. Symplekin, a novel type of tight junction plaque protein. J Cell Biol 1996;134:1003-18.
  • Zhong Y, Saitoh T, Minase T, Sawada N, Enomoto K, Mori M. Monolonal antibody 7H6 reacts with a novel tight junction-associated protein distinct from ZO-1, cingulin and ZO-2. J Cell Biol 1993;120:477-83.
  • Yamamoto T, Harada N, Kano K, et al. The ras target AF-6 interacts with ZO-1 and serves as a peripheral component of tight junctions in epithelial cells. J Cell Biol 1997;139:785-95.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.